Daniel Ehrsam has done his graduation in Pharmaceutical Sciences from the University of Basel in 2014. He did his master’s research work on brain ischemia pathways under supervision of Dr. Margaret Weiss at Texas Tech Health Science Center. He has worked at the Swiss Tropical and Public Health Institute on helminth drug development. In 2015, he joined the research group of professor Dr. Henriette E Meyer zu Schwabedissen for his PhD studies. His research is focused on the development of an enzyme based targeted drug delivery system. Daniel Ehrsam has done his graduation in Pharmaceutical Sciences from the University of Basel in 2014. He did his master’s research work on brain ischemia pathways under supervision of Dr. Margaret Weiss at Texas Tech Health Science Center. He has worked at the Swiss Tropical and Public Health Institute on helminth drug development. In 2015, he joined the research group of professor Dr. Henriette E Meyer zu Schwabedissen for his PhD studies. His research is focused on the development of an enzyme based targeted drug delivery system.
Medicinal chemistry